f.yildiz
TL2 · Bergen
Contributes reviews on supplier material. Based in Bergen.
Joined 2 February 2025 · last posted 9d
98Posts here
2Topics
0Solutions
862Likes received
664Likes given
20Badges
210Days visited
3.4kPosts read
Recent activity
Full stream-
What is genuinely unknown about long-term amylin agonism Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 31 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #62 · Compounds › Repair & healing peptides · 19 Jul 2026 · 1 like Answering the question post #60 raises rather than the one it answers. Nothing in this subcategory is medical advice and several members here are describing experiments…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #27 · Sourcing › Regulatory · 16 Jul 2026 · 0 likes No notes. Posting so the count is not one.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #34 · Compounds › Retatrutide · 14 Jul 2026 · 3 likes Glucagon receptor agonist is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
How shortages have affected compounding permissions Replied, post #34 · Access › Shortages · 13 Jul 2026 · 2 likes What would change my mind on shortages is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
-
Journal club: what we got wrong in an earlier session Replied, post #78 · Evidence › Journal club · 13 Jul 2026 · 30 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. That is the…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #39 · Practice › Side effects · 9 Jul 2026 · 31 likes The bit of Muscle cramps that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Submitting a sample: the process end to end Replied, post #53 · Sourcing › Independent verification · 2 Jul 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Trying to state the submitting a sample position in a way that someone who…
-
Tracking a shortage from primary sources rather than rumour Replied, post #75 · Access › Shortages · 29 Jun 2026 · 4 likes Post #74 is the version of this I will quote in future. One addition. Tracking a shortage came up in a thread eighteen months ago and was answered well. I cannot find…
-
Tracking intake honestly when appetite is absent Replied, post #60 · Nutrition & Training › Protein & intake · 15 Jun 2026 · 0 likes The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores the actual constraint. It is worth checking…
-
Electrolyte supplements: which ones do anything Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 10 Jun 2026 · 7 likes This follows post #24 rather than contradicting it. Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #104 · Practice › Storage & stability · 9 Jun 2026 · 0 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again.